Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling.

["Feetham CH", "Collabolletta V", "Worth AA", "Shoop R", "Groom S", "Harding C", "Boutagouga Boudjadja M", "Coskun T", "Emmerson PJ", "D'Agostino G", "Luckman SM"]
Nature communications 2024
Open on PubMed

Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor &#x3b1;-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF<sup>mNTS</sup> neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF<sup>mNTS</sup> neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.